Identification of antifungal compounds in a biological control product using a microplate inhibition bioassay

Transactions of the ASABE

Volumn 49, Issue 5, 2006, Pages 1643-1649

  Pryor, Scott W ^a   Gibson, Donna M ^b   Krasnoff, Stuart B ^b   Walker, Larry P ^c,d  

^a North Dakota State University   (United States)

^b ROBERT W HOLLEY CENTER FOR AGRICULTURE AND HEALTH   (United States)

^c Department of Biological and Environmental Engineering   (United States)

^d Department of Obstetrics Gynecology   (United States)

Author keywords

Bacillus subtilis; Biological control; Fengycin; Iturin A; Lipopeptides; Microplate bioassay

Indexed keywords

BACILLUS SUBTILIS; BIOLOGICAL CONTROL; FENGYCIN; ITURIN A; LIPOPEPTIDES; MICROPLATE BIOASSAY;

AMINO ACIDS; BACTERIA; FERMENTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHANOL;

BIOASSAY;

ANALYTICAL METHOD; BACTERIUM; BIOASSAY; BIOLOGICAL CONTROL; FERMENTATION; FUNGUS; IDENTIFICATION METHOD; METHANOL; PATHOGEN; PEPTIDE; SPORULATION;

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); FUSARIUM OXYSPORUM; FUSARIUM OXYSPORUM F. SP. MELONIS;

EID: 33845658649     PISSN: 21510032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Akpa, E., P. Jacques, B. Wathelet, M. Paquot, R. Fuchs, H, Budzikiewicz, and P. Thonart. 2001. Influence of culture conditions on lipopeptide production by Bacillus subtilis. Applied Biochem. and Biotech. 91-93: 551-562.
2. Bergstrom, G. C., and W. C. da Luz. 2005. Biocontrol for plants with Bacillus subtilis, Pseudomonas putida, and Sporobolomyces roseus. Ithaca, N.Y.: Cornell Research Foundation, Inc., and Passo Fundo, Brazil: Embrapa Trigo.
3. Besson, F., C. Chevanet, and G. Michel. 1987. Influence of the culture-medium on the production of iturin A by Bacillus subtilis. J. General Microbiology 133(4): 767-772.
4. Bevington, P. R., and D. K. Robinson. 1992. Data Reduction and Error Analysis for the Physical Sciences. Boston, Mass.: WCB/McGraw-Hill.
5. Hadacek, F., and H. Greger. 2000. Testing of antifungal natural products: Methodologies, comparability of results and assay choice. Phytochem. Analysis 11(3): 137-147.
6. Heins, S. D., D. C. Manker, D. R. Jimenez, R. J. McCoy, P. G. Marrone, and J. E. Orjala. 2002. Compositions and methods for controlling plant pests. Davis, Cal.: AgraQuest, Inc.
7. Jacques, P., C. Hbid, J. Destain, H. Razafindralambo, M. Paquot, E. De Pauw, and P. Thonart. 1999. Optimization of biosurfactant lipopeptide production from Bacillus subtilis S499 by Plackett-Burman design. Applied Biochem. and Biotech. 77-79: 223-234.
8. Kajimura, Y., M. Sugiyama, and M. Kaneda. 1995. Bacillopeptins, new cyclic lipopeptide antibiotics from Bacillus subtilis Fr-2. J. Antibiotics 48(10): 1095-1103.
9. Magetdana, R., and F. Peypoux. 1994. Iturins, a special class of pore-forming lipopeptides: Biological and physicochemical properties. Toxicology 87(1-3): 151-174.
10. Mannanov, R. N., and R. K. Sattarova. 2001. Antibiotics produced by Bacillus bacteria. Chem. of Natural Compounds 37(2): 117-123.
11. Moyne, A. L., R. Shelby, T. E. Cleveland, and S. Tuzun. 2001. Bacillomycin D: An iturin with antifungal activity against Aspergillus flavus. J. Applied Microbiology 90(4): 622-629.
12. Nakayama, S., S. Takahashi, M. Hirai, and M. Shoda. 1997. Isolation of new variants of surfactin by a recombinant Bacillus subtilis. Applied Microbiology and Biotech. 48(1): 80-82.
13. Ohno, A., T. Ano, and M. Shoda. 1992. Production of antifungal antibiotic iturin in a solid-state fermentation by Bacillus subtilis Nb22 using wheat bran as a substrate. Biotech. Letters 14(9): 817-822.
14. Ozcengiz, G., and N. G. Alaeddinoglu. 1991. Bacilysin production by Bacillus subtilis: Effects of bacilysin, pH, and temperature. Folia Microbiologica 36(6): 522-526.
15. Perlack, R. D., L. W. Wright, A. F. Turhollow, R. L. Graham, B. J. Stokes, and D. C. Erbach. 2005. Biomass as Feedstock for a Bioenergy and Bioproducts Industry: The Technical Feasibility of a Billion-Ton Annual Supply. Oak Ridge, Tenn.: Oak Ridge National Laboratory.
16. Richard, T. 1997. The kinetics of solid-state aerobic biodegradation. PhD diss. Ithaca, N.Y.: Cornell University, Department of Agricultural and Biological Engineering.
17. Schneider, J., K. Taraz, H. Budzikiewicz, M. Deleu, P. Thonart, and P. Jacques. 1999. The structure of two fengycins from Bacillus subtilis S499. Zeitschrift fur Naturforschung C 54(11): 859-866.
18. Thimon, L., F. Peypoux, R. Magetdana, B. Roux, and G. Michel. 1992. Interactions of bioactive lipopeptides, iturin A, and surfactin from Bacillus subtilis. Biotech. and Applied Biochem. 16(2): 144-151.
19. Toure, Y., M. Ongena, P. Jacques, A. Guiro, and P. Thonart. 2004. Role of lipopeptides produced by Bacillus subtilis GA1 in the reduction of grey mould disease caused by Botrytis cinerea on apple. J. Applied Microbiology 96(5): 1151-1160.
20. Umezawa, H., T. Aoyagi, T. Nishikiori, A. Okuyama, Y. Yamagishi, M. Hamada, and T. Takeuchi. 1986. Plipastatins - New inhibitors of phospholipase-A2, produced by Bacillus cereus Bmg302-Ff67: 1. Taxonomy, production, isolation, and preliminary characterization. J. Antibiotics 39(6): 737-744.
21. Vanittanakom, N., W. Loeffler, U. Koch, and G. Jung. 1986. Fengycin: A novel antifungal lipopeptide antibiotic produced by Bacillus subtilis F-29-3. J. Antibiotics 39(7): 888-901.
22. Wedge, D. E., J. C. G. Galindo, and F. A. Macias. 2000. Fungicidal activity of natural and synthetic sesquiterpene lactone analogs. Phytochem. 53(7): 747-757.
23. Yamada, S., Y. Takayama, M. Yamanaka, K. Ko, and I. Yamaguchi. 1990. Biological activity of antifungal substances produced by Bacillus subtilis. J. Pesticide Sci. 15(1): 95-96.
24. Zuniga, T. L., T. A. Zitter, T. R. Gordon, D. T. Schroeder, and D. Okamoto. 1997. Characterization of pathogenic races of Fusarium oxysporum f. sp. melonis causing Fusarium wilt of melon in New York. Plant Disease 81(6): 592-596.